RDCD Stock Overview
Operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Redcare Pharmacy NV Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €117.40 |
52 Week High | €144.13 |
52 Week Low | €95.51 |
Beta | 1.03 |
11 Month Change | -11.53% |
3 Month Change | n/a |
1 Year Change | 18.81% |
33 Year Change | -16.20% |
5 Year Change | 228.85% |
Change since IPO | 201.03% |
Recent News & Updates
Recent updates
Shareholder Returns
RDCD | GB Consumer Retailing | GB Market | |
---|---|---|---|
7D | 0% | -0.8% | -0.7% |
1Y | 18.8% | 20.3% | 6.7% |
Return vs Industry: RDCD underperformed the UK Consumer Retailing industry which returned 20.3% over the past year.
Return vs Market: RDCD exceeded the UK Market which returned 6.7% over the past year.
Price Volatility
RDCD volatility | |
---|---|
RDCD Average Weekly Movement | n/a |
Consumer Retailing Industry Average Movement | 3.7% |
Market Average Movement | 4.6% |
10% most volatile stocks in GB Market | 9.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: RDCD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RDCD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 1,900 | Olaf Heinrich | www.redcare-pharmacy.com |
Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023.
Redcare Pharmacy NV Fundamentals Summary
RDCD fundamental statistics | |
---|---|
Market cap | €2.45b |
Earnings (TTM) | -€9.33m |
Revenue (TTM) | €2.13b |
1.2x
P/S Ratio-262.2x
P/E RatioIs RDCD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RDCD income statement (TTM) | |
---|---|
Revenue | €2.13b |
Cost of Revenue | €1.63b |
Gross Profit | €492.74m |
Other Expenses | €502.07m |
Earnings | -€9.33m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 05, 2024
Earnings per share (EPS) | -0.46 |
Gross Margin | 23.16% |
Net Profit Margin | -0.44% |
Debt/Equity Ratio | 45.3% |
How did RDCD perform over the long term?
See historical performance and comparison